SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
COVID-19 gout treatment trial to include under-50s
Fri March 5th - A UK COVID-19 trial that is assessing the effectiveness of a common gout drug to help alleviate the virus’s symptoms can now include under-50s, it has been announced. More
Warning as virus surges across Europe
Fri March 5th - Europe is seeing a resurgence of COVID-19 infection driven by new variants, the World Health Organisation has warned. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
Pharmaceuticals

Pharmaceuticals

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57

05/03/2021 - COVID-19 gout treatment trial to include under-50s
A UK COVID-19 trial that is assessing the effectiveness of a common gout drug to help alleviate the virus’s symptoms can now include under-50s, it has been announced. More

04/03/2021 - Treatment hope after rare cancer origin discovered
The origin of a rare childhood cancer has been discovered – and a possible drug treatment. More

02/03/2021 - How first dose has saved lives
The first dose of vaccine has cut rates of COVID-19 disease among elderly people by about two thirds, according to a major analysis published yesterday. More

26/02/2021 - COVID vaccination gives huge boost to post-infection immunity
Vaccination is acting as a booster dose for people already enjoying some protection against COVID-19 after exposure to the disease, British scientists reported last night. More

25/02/2021 - Muscle pain not affected by statins
Muscle pain is not exacerbated by the use of statins, according to the results of a UK trial, published today. More

23/02/2021 - How UK vaccination is saving many from the virus
The first dose of the first COVID-19 vaccine has cut risk of dying from the virus by three quarters among its first elderly recipients, according to “early data”, released yesterday. More

17/02/2021 - Therapy might block multiple sclerosis autoimmune process
A new study has shown how harmful immune cells travel to the brain in people with multiple sclerosis and lead to disease progression. More

15/02/2021 - COVID phase one trials get UK bulk test approach
The UK is to adapt an innovative clinical trial procedure in a bid to fast-track untested new drugs for COVID-19 treatment, it has been announced. More

12/02/2021 - Acupressure backed for severe pregnancy sickness
Women with severe pregnancy sickness can be offered acupressure and antiemetics, according to new official guidance. More

11/02/2021 - Opioids and macrolides 'safe' in pregnancy
No links have been found between taking prescription opioids or macrolide antibiotics during pregnancy and an increased risk of major birth defects, two new studies report today. More

11/02/2021 - Oxford vaccine prevents hospital admission - WHO
The Oxford University COVID-19 vaccine has gained key backing from international experts after a series of controversies. More

10/02/2021 - Asthma linked to antibiotic exposure in utero
Children born to women who took antibiotics in mid or late pregnancy may have a raised risk of asthma, researchers report today. More

08/02/2021 - South African variant evades vaccine
The Oxford adenoviral vaccine has had little success in preventing infection with the South African mutation of COVID-19, it has been announced raising new concerns about the virus’s ability to mutate to avoid vaccines. More

05/02/2021 - Gout drug aids COVID-19 patients
A cheap drug used to treat gout helps to reduce the need for oxygen therapy among the most ill COVID-19 patients, according to the results of a small clinical trial. More

04/02/2021 - UK to test mixed vaccine doses
More than 800 people in the UK will take part in the world’s first trial of mixing the two major kinds of COVID-19 vaccine in a £7 million study, it was announced today. More

03/02/2021 - Antiviral drug may fight COVID-19
An antiviral drug based on a traditional Mediterranean remedy is showing promising results against COVID-19 infection, scientists have reported. More

03/02/2021 - 12 week vaccine booster delay unexpectedly effective
The British government gambled correctly when it decided to extend the interval for booster vaccine doses to 12 weeks, according to a significant new analysis. More

01/02/2021 - Virus variant study raises vaccine concerns
The SARS-COv-2 virus began mutating to avoid human immunity in the spring last year - raising concerns about the durability of the current vaccines, according to the findings of a major UK scientific study. More

29/01/2021 - Metformin may affect breast cancer risk
Metformin could affect a woman's risk of developing breast cancer, a USA study published today has suggested. More

21/01/2021 - Antidepressants 'ineffective' for back pain and osteoarthritis
Antidepressant drugs do not provide any benefit for people with back and osteoarthritis pain, according to a review published. More

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57

Printer friendly page Printer friendly page

CATEGORIES